The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04636034

Recruitment Status : Recruiting

First Posted : November 19, 2020

Last Update Posted : April 29, 2022

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

Mads Seit Jespersen, University Hospital Bispebjerg and Frederiksberg

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	April 2022
Estimated Study Completion Date :	April 2022

To Top